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The microbial risk to aseptically manufactured products in pharmaceutical cleanrooms can be
assessed by the use of fundamental equations that model the dispersion, transfer and deposition of
microbial contamination, and the use of numerical values or risk descriptors. This can be done in
two-stages, with the first stage used to assess the transfer of contamination from all of the sources
within the cleanroom suite and the second stage used to assess both air and surface contact
contamination within critical production areas. These two methods can be used to assess and reduce
microbial risk at the preliminary design stage of the cleanroom and associated manufacturing
process or, retrospectively, for an established manufacturing operation.
Introduction
A number of systems exist for managing risk during
manufacturing. These include Fault Tree Analysis (FTA)1,
Failure Mode and Effect Analysis (FMEA)2, Hazard and
Operational Studies (HAZOP)3, and Hazard Analysis and
Critical Control Point (HACCP)4. The HACCP system,
having been developed for the food industry, appears to be the
most suitable risk management system for the methodical
assessment, control and monitoring of microbial risk in the
pharmaceutical industry5.
An important part of a risk management system is the risk
assessment process, where the importance or degree of risk
associated with each identified hazard is assessed. Each
hazard is assigned a numerical value or descriptor of risk.
Those hazards with a high degree of risk can then be
considered further in order to reduce the risk to a more
acceptable level. A useful risk assessment method is the
FMECA criticality method outlined in International
Electronic Commission report on the procedure for Failure
Mode and Effect Analysis (FMEA)2. The FMECA method is
based on the following equation:
Equation 1
Risk = criticality of the occurrence × frequency of occurrence
This risk equation was considered in a previously published
paper6, and shown to be more correct than a similar equation
that includes a third variable of ‘detection’. It was also
established that ‘criticality’, when considering microbial
contamination, reflects the importance of a hazard in terms of
the number of microbes from the hazard i.e. source, that are
deposited onto the product; this should be expressed in terms
of the concentration of microbes on, or in, a source, and their
likelihood of dispersion, transfer, and deposition. The
‘frequency’ variable should be expressed as either the time
the product is exposed, or the frequency of contamination
incidents. If this is accepted, then the criticality risk
assessment Equation 1 is the same as the fundamental
equations described below, and its scientific basis vindicated.
To accurately assess microbial risk, the basic models of
risk must be known so that the fundamental variables that
predict risk and their importance in relation to the other
variables can be determined. The overall equation that applies
to the risk of microbial contamination of a product has been
derived6 and is as follows: 
Equation 2
No. of microbes deposited on a product = C ×S ×Pd ×Pa ×A ×T
where:
C = concentration of microbial contamination on, or in, a source
(number/cm2 for a surface, or number/cm3 for air);
S = the quantity of surface material, or air, that is dispersed, from a source
in a given time (cm2 /s for surfaces, and cm3 /s for air dispersion); this
can also be expressed as the quantity dispersed per frequency of
occurrence;
Pd = proportion of microorganisms dispersed from a source that are
transferred to the area adjacent to the product;
P
a
= proportion of microorganisms in the adjacent area that are deposited
per unit area of the product (/cm2);
A = area of surface onto which microbes are deposit (cm2);
T = time, during which transfers occur(s); this can also be expressed as
frequency of occurrence.
Two simplified versions of Equation 2 were derived6 to
model surface contact and airborne deposition of microbes
into, or onto, a product. Equation 3 models surface contact
contamination:
Equation 3
Number of microorganisms deposited by surface contact over
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deposition of microbes from cleanroom air is continuous,
the rate not varying significantly during production. Also,
the frequency of incidents of surface contamination, such as
when personnel touch the product, is normally unknown,
personnel often being unaware of its occurrence. Thus, for
the purpose of an overall risk assessment, the variable of
time (T) is not used. Numerical information is also rarely
available about the dispersion, transfer and deposition of
micro-organisms. Consequently, a simplified version of the
equation using surrogate descriptors for these unattainable
variables is shown as Equation 5 and should be used for the
analysis.
Equation 5
Risk from microbial contamination (risk rating) = A ×B ×C ×D
where:
A = microbial contamination on, or in, a source;
B = ease of dispersion and transfer;
C = proximity of source from critical area;
D = effectiveness of control method.
The risk rating of each source is determined by assigning
risk scores to risk factors A to D. Given in Table 1 is an
example of risk scores that can be used. It should be noted
that the chance of transfer of contamination (risk factor C)
is assessed from the distance the source is from the
product. This is a reasonable approach, but may need
modification in some circumstances e.g. a person
upstream of the product in a unidirectional air flow will
have a different chance of contaminating the product than
someone standing the same distance downstream. Other
risk factors may need similar modification.
A comprehensive identification of all the sources of
microbial risk, is fundamental to the success of this
approach. A method to identify and group sources of
microbial contamination has been discussed by Whyte5.
Shown in Figure 1, in Mind Map format, are the
groupings of microbial sources that should be considered.
During an actual assessment, a more extensive
identification of sources is expected. Also shown in
Figure 1 are the connections between people and other
sources, emphasising the fact that people are the primary
source of microbes in a cleanroom.
a given time (no.) = microbes on contaminating surface
(no./cm2) x transfer coefficient x area of product that is
contacted (cm2) × frequency of contact
where:
the ‘transfer coefficient’ is the proportion of microorganisms on a
contaminating surface (such as a glove) that are transferred to the
product.
Equation 4 models airborne deposition onto a product
and is as follows:
Equation 4
Number of airborne microorganisms deposited onto the
product in a given time (no.) = deposition rate of microbe
carrying particles (no./(cm2.s)) x area of product exposed
(cm2) x time of exposure (s)
Most microbes in the cleanroom air are rafted on particles
of skin, their average size being between about 8µm and
20µm and these microbe carrying particles will deposit
into the product, mainly by gravity7. The deposition rate
of microbe carrying particles into, or onto, a product can
be ascertained from settle plates exposed adjacent to the
exposed product8.
To obtain the most accurate estimate of the amount of
microbial contamination by airborne deposition or surface
contact, numerical values should be substituted into the
above equations. However, in pharmaceutical production,
much of this numerical information is unknown and it is
therefore necessary to employ risk assessment methods
using descriptors that act as surrogates for the required
numerical data. To obtain the highest degree of accuracy
from the use of descriptors, those that best describe the
variables in the above equations should be chosen. They
should be combined as indicated in the equations, so that
the relative importance of the variables is retained. This
can be done using the FMECA method as described in the
following sections of this paper.
Overall deposition model
It is useful to start a microbial risk assessment of a
pharmaceutical production area by considering all of the
microbial hazards in the various clean
areas in the manufacturing suite; a
detailed consideration of critical areas
will be carried out later. In this paper,
all microbial sources are considered to
be potential hazards. To carry out an
overall risk assessment, the analysis
should be based on Equation 2. The
concentration of microbes in the air, or
on surfaces, is one of the required
variables and numerical values should
be available, and used. However,
numerical values are likely to be
unavailable for other variables in the
equation. The time duration, or
frequency of microbial contamination
in cleanroom, can be continuous or
unknown. For example, the rate of
Table 1: Scores for risk factors used for assessing hazards
Risk factor (A) Risk factor (B) Risk factor (C) Risk factor (D)
Amount of microbial Ease of dispersion, Proximity (location) Effectiveness 
contamination or transfer, of of source from of control 
on, or in, a source microorganisms critical area method
0 = nil 0 = nil 0 = remote 0 = full barrier control*
0.5 = very low 0.5 = very low 0.5 = in outside 0.5 = very good control
corridor, air lock
1 = low 1 = low 1 = periphery of 1 = good control
cleanroom
1.5 = medium 1.5 = medium 1.5 = general 1.5 = some control
area of cleanroom
2 = high 2 = high 2 = critical area 2 = no control
*Complete physical barrier between source and critical area
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It is now possible to obtain a risk rating by assessing
each identified source and assigning risk scores to the four
risk factors. Shown in Table 2 is the first line of such a
resultant assessment with a set of assigned scores and the
risk rating obtained.
From the risk rating values, the importance of each
source can be assigned a risk rating of ‘high’, ‘medium’ or
‘low’. For example, hazards that have a risk rating of: 
(a) 4 and over may be considered as ‘high’; 
(b) below 4, and over or equal to 2, as ‘medium’; and
(c) less than 2 as ‘low’. 
The designation of ‘high’ to a source does not mean that it
has a high risk to the product, but within a list of possible
hazards it is likely to be one with a higher degree of risk.
Hazards with a ‘high’ or ‘medium’ risk can then be further
considered with a view to reducing their risk. This can be
done by reducing the risk scores of one or more of factors
A to D.
The list of sources, and their risk ratings, can then be
used in subsequent parts of a risk management analysis
based on HACCP, to determine whether adequate control
methods are used, and if the risks or their control methods
are adequately monitored. This is can be done as indicated
in Table 3, where the sources assessed previously are
further considered. The HACCP system can then be
further utilised to set monitoring schedules, appropriate
action and alert limits, verify that the system works,
prepare documentation and implement training5.
Critical area risk assessment method
The method of assessing risk described in the previous
section is used to carry out an overall assessment of all
microbial risks in all areas of the pharmaceutical
Figure 1.Microbial sources in a cleanroom.
Table 2. Calculation of the risk rating for an identified source.
Group and Source Risk factor A. Risk factor B. Risk factor C. Risk factor D. Risk rating
Conc. of microbes Ease of movement to Proximity to product Effectiveness of 
product control (method given)
1. Areas adjacent to 
production cleanroom
1.a Air outside 
production cleanroom 
(corridor) 1.5 1 0.5 1  (positive outflow from 0.75
the cleanroom and 
air dilution in corridors)
Table 3. List of sources with risk rating and consideration of a suitable control and valid monitoring methods
Source to be controlled Risk rating Suitable control method Valid monitoring methods
1. Areas adjacent to 
critical area
1.a. Air outside production 
cleanroom (corridor) 0.75 Adequate air ventilation conditions 1. air supply volumes;
2. air pressurisation;
3. airborne particle conc.;
4. settle plates and airborne microbial sampling.
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production cleanroom suite. However, it will normally be
found that the highest risk occurs in the critical area where
the product is open to contamination. A more detailed risk
assessment of the critical area may then be required to
assess: 
(1) microbial contamination coming from contaminating
surfaces, such as gloves or clothing, touching the
product; and 
(2) the deposition of microbe carrying particles from the
air. 
It is necessary to assess these two routes separately, as the
numerical values or descriptors used are basically
different, and when steps are taken to minimise risks, the
methods used will also be different.
Surface contact contamination
Surface contact contamination can occur during the
following stages of manufacture:
1. Transfers into the critical area;
2. Setting-up of production machinery;
3. Normal production;
4. Interventions.
The overall risk to the product by surface contact can be
assessed by adding the risk from each of these stages, as
shown in Equation 6.
Equation 6
Risk by surface contact = 
risk from critical transfers + risk from setting up + risk
during normal production + risk during interventions
When developing risk equations it is important to decide
whether the risk factors should be multiplied, or added, as
this has a substantial effect on the accuracy of the risk
assessment. If risk factors are independent of each other,
then they should be added together; this is the situation in
Equation 6 where the risk of contamination in one stage of
production has no direct influence on any other stage.
However, if the risk factors are dependent on each other,
then they should be multiplied. This is the case with the
variables in the fundamental Equations 2, 3 and 4, as each
variable (risk factor) is dependant on the others to
determine the overall magnitude of the risk of
contamination. One example of a dependent risk factor is
time, as the time the product is exposed to contamination
directly influences, or ‘gears up’, the degree of risk of the
other risk factors. A practical way of deciding whether to
add or multiply risk factors is to allocate zero to a risk
factor, and find out if the result is the one that is anticipated
It is now necessary to model the risk of each of the four
stages given in Equation 6. It is not sufficient to list all of
the factors thought to cause microbial risk during
production, and multiply or add their risk scores together.
If this is done, inaccuracies will emerge. For example, if
two or more descriptors are used to describe the risk
caused by the same fundamental variable, then the
importance of that variable will be exaggerated, especially
if the risk scores are multiplied together. Numerical
values, or descriptors, should therefore be chosen to
measure or describe the variables in the surface contact
contamination Equation 3, and combined as indicated in
Equation 6.
The first variable in Equation 3 is microbial
contamination on contacting surfaces. This variable is not
used here, because many surfaces are not sampled for
microbial contamination. If they are, they will be often
found to be sterile, or any counts may be inaccurate
because of the introduction of microorganisms during the
sampling. However, if reliable surface concentration
results are available then these can be included to improve
the risk estimate. The second variable in Equation 3 is the
transfer coefficient relating to the proportion of surface
contamination that is transferred from the contaminating
surface to the product. It is highly unlikely that any
numerical values will be available for this variable, and
descriptors should be used. The third variable is the area
of the product that is contacted. If this varies between
different stages of the process, then this variable should be
incorporated to improve the risk analysis. However, it will
be more common that the area will remain constant, and
there is no advantage in including this variable. The
variable of time, or frequency, which was not used as a
risk variable in the overall risk assessment discussed
above, is used here, as it is likely to be available, or can be
determined. Time can be expressed either as the time the
product is exposed to contamination, or the frequency of a
contamination incident occurring. Utilising these
assumptions, a simple risk equation that combines the
surface contact contamination from the four stages of
manufacture is given in Equation 7.
Equation 7
Risk by surface contact = α [no. of critical transfers] 
+ β [setting up complexity] + χ [operator involvement 
× complexity of critical area × no. of manipulations] 
+ δ [no. of interventions]
Where α, β, χ and δ are weighting coefficients 
It can be seen in this equation that the ‘risk during normal
production’ variable indicated in Equation 6 now
comprises of three risk descriptors. As these three
descriptors are relatively dependent on each other, they
need to be multiplied together. However, this combined risk
score will be much greater than any of the other three
stages. In addition, some stages are more likely to
contribute more surface contamination e.g. interventions
than other stages. These imbalances in the risk equation can
be corrected by assigning weighting coefficients. These
were shown in Equation 7 as α, β, χ and δ, and examples of
values that can be assigned are shown in Equation 8:
Equation 8
Risk by surface contact = 1 × [no. of critical transfers] 
+ 1.5 × [setting up complexity] + 0.5 x [body involvement
× complexity of critical area × no. of manipulations] 
+ 2 × [no. of interventions]
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It is now necessary to allocate risk scores to each risk
factor in Equation 8. Risk scores are usually assigned by
an aggregation of opinion from an expert committee set up
to carry out this task. Some scoring systems use only
numerical values, and these may range as high as from 0
to 10. However, it is unrealistic to expect that risk can be
allocated in such fine divisions, and a range of no more
than six levels is reasonable. It is also easier for a person to
describe risk by one or two simple words that can be
allocated a number e.g. not possible = 0, very unlikely = 1,
unlikely = 2, possible = 3, likely = 4, very likely = 5,
definite = 6. It is difficult to find a scoring system that is
free of criticism but a simple 4-level system is used here
i.e. nil - 0, low-1, medium-2 and high-3.
Given in Table 4 is an example of surface contact risk
factors and associated scores which could be applied to a
manufacturing process. This should be modified to fit the
process being investigated. It should also be noted that
when constructing a risk score table the normal range of
occurrence should be evenly spread to match the range of
the risk scores. This is especially important if different
stages, or phases, of production have to be compared. The
scores allocated are then used with Equation 8 to obtain a
‘risk rating’. 
Risk ratings can now be used to see where improvements
are best made to reduce the risk. An example is given.
Example: A cleanroom has a filling machine used for
aseptic filling of vials that is located within a
unidirectional flow workstation. Vials are fed to the point-
of-fill through a hot-air depyrogenation tunnel. Product
solution, stored in a sterilized holding tank, is fed to the
filling machine through sterilizing grade filters and filled
into the vials. Lyophilisation stoppers, transferred into the
filling area, are partially seated onto the vials, which are
accumulated into a mobile isolator, transferred into a
sterilized freeze drier, and dried. The stoppers are then
fully seated before being removed from the freeze drier for
capping and crimping. The risk scores (bold) for each risk
factor, and the risk rating, as calculated by Equation 8 for
the four stages, are given in Table 5.
Table 5 indicates that the filling and stoppering stage
had the highest risk assessment and the operations of this
stage should be targeted to reduce the contact surface
risk. Risk factors were addressed in the following manner:
Table 4. Risk factors and scores used to assess contamination contact surface risks per production batch
Manufacturing Stage Risk factor Risk score 0 Risk  score 1 Risk score 2 Risk score 3 = high
= nil = low = medium
Transfers into the Number of critical None No more than 10 No more than 30 More than 30
Critical Areas transfers
Setting up Production Setting up complexity No set up activities Not complex. More complex. Complex. Time to set 
Machinery Time to set up no Time to set up no up more than 30 min
more than 10 min more than 30 min
Normal Production Operator involvement None Hands Hands and arms Body
Complexity of critical Not Applicable Simple Some complexity Complex
area
Number of 
manipulations None No more than No more than More than 50% 
5% of time 50% of time of time
Interventions Number of interventions None No more than 5 No more than 10 More than 10
Table 5. Risk scores and risk ratings for contact surface risk for all manufacturing stages
Manufacturing Transfers into Setting up Normal Normal Normal Interventions Risk rating*
phase the Critical Production Production Production Production 
Areas Machinery
Number of   Body Complexity of 
manipulations involvement critical area
(% of total time)
(A) (B) (C1) (C2) (C3) (D)
Vial washing and None None 1% None Simple 1
sterilisation score=0 score=0 score=1 score=0 score=1 score=1 2.0
Solution storage 3 5 min 1% None Simple None
score=1 score=1 score=1 score=0 score=1 score=0 2.5
Filling and stopper 50 35 min 3% None Simple 38
placement score=3 score=3 score=1 score=0 score=1 score=3 10.5
Freeze drying and 150 5 min One None Simple None 4.5
capping score=3 score=1 manipulation score=0 score=1 score=0
score=0.5
* Risk rating = [1 x A] + [1.5 x B] + 0.5[C1 x C2 x C3] + [2 x D]
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1. The number of critical transfers: The vial stoppers were
supplied in bags of 500. With a single batch size of up
to 25,000 units, up to 50 critical transfers were
required. As the stopper feed bowl had adequate
capacity, the stoppers were supplied in bags of 1000,
reducing the number of transfers by a factor of 50%. 
2. Filling machine set up complexity and time: Control
of filling volume was achieved via a time-pressure
system with a high level of automated control.
However, this required a complex aseptic assembly of
machine parts that took on average 35 minutes to
complete. Modifications to the pipework were
undertaken, whilst maintaining its cleaning and
sterilisation functionality. The resultant assembly
operation utilised less parts, was less complex, and
had an average assembly time of 9 minutes.
3. The number of interventions: Stopper-to-stopper
adhesion, a consequence of the sterilisation process,
resulted in feedbowl blockage, which then required
manual removal with sterilised forceps.
Modifications to the feed bowl, to automatically
reject adhered stoppers, reduced the average number
of interventions from 38 to 4.
The above modifications reduced the risk rating of the
filling and stoppering stage from 10.5 to 5.5.
The risk occurring during an individual manufacturing
stage can, if required, be investigated in more detail. For
example, the setting-up stage may be complex, with a
large number of steps. The FMECA Equation 1 given in
the introduction of this paper can be used:
Risk = criticality of the occurrence x frequency of occurrence
The stage to be investigated should be broken down into
individual steps. The risk scoring system should be set and
scores allocated to the ‘criticality’ and ‘time’ for each
step, these being multiplied together to obtain a risk
rating. For illustration purposes, and using an arbitrary
scoring system, a single step is shown in Table 4.
‘Criticality’ expresses the importance of a source, and
it has been shown in Section 1 that it should be expressed
in terms of the microbial concentration of the
contaminating surface and the likelihood that these
microbes are dispersed, transferred, and then deposited
onto the product. As shown in Table 6, microbial
concentration of the contaminating surface can be scored
and an overall score used for the component of dispersion,
transfer and deposition (these three components can also
be scored individually if required). Time may be scored in
relation to the time the product is exposed to
contamination, or as contamination incidence frequency.
Risk assessment of airborne deposition
Airborne deposition using sampling results
Equation 4 is the fundamental equation used to calculate
airborne dispersion onto or into, pharmaceutical products.
This equation has been shown to predict airborne
contamination over a wide range of conditions during
pharmaceutical production8. The variables required for
solution of the equation are:
Microbial deposition rate: This can be obtained from
the counts on settle plates exposed adjacent to the product.
The results from settle plates are commonly reported as:
number of colony forming units (cfus) settling onto a
settle plate of a given area exposed over a given period of
time. This is a deposition rate, but for our purposes must
be presented in a more scientific way: cfus/cm2/hour is the
most convenient. To achieve an accurate simulation of
contamination, settle plates must be positioned adjacent to
the exposed product and open only when contamination
occurs; this can be done by opening and closing the plates
when production starts and stops. However, the plate
should remain open if production stops and an unplanned
intervention is necessary when the product is still
exposed. Settle plates 9cm in diameter (64 cm2 in area) are
normally exposed for four hours, although larger 14 cm
diameter plates (154cm2 area), exposed for the same
period, will give more accurate counts. Settle plate counts
taken in cleanrooms often give a series of zero results,
with an occasional positive. This lack of sensitivity can be
improved by using the larger plates during a period of
high sampling intensity, or combining results obtained
from routine sampling results, and averaging them over a
one or two year period.
It is necessary to check that dehydration of the
microbiological medium in the settle plates, caused by air
movement, does not reduce the count. Experience shows
that as long as the plate is well filled with agar medium,
and its exposure in unidirectional flow is not much over
four hours, the resultant count is not significantly
affected9. However, it is necessary to confirm this on an
individual basis.
Surface area: The surface area of the product exposed
to airborne contamination is required. As it is known that
gravitational settling mainly governs the deposition of
microbe carrying particles during pharmaceutical
manufacturing7, 10, only the horizontal area of the exposed
product is required. This might be the area of the inner
neck of a container, or the upwards-facing area of a solid
product.
Time product exposed: The time the product is exposed
to airborne microbial contamination is required. The total
manufacturing time should not be used, but the average
time a single product is exposed to the
airborne environment. For example, the
first product through a filling line may
be exposed for only a few seconds, but
the last one will be exposed for the total
time of the process; the average
exposure time is therefore 50% of the
total process time. If a holding area e.g.
turntable or hopper is loaded in batches
Table 6. Calculation of risk rating for an individual step
Criticality        × Time        = Risk rating
Score of ‘concentration Score of ‘dispersion Score of ‘time, C x D.T.D x T
of microbes (C)’ x transportation or frequency (T)’
x deposition (D.T.P)’
1 x 3 x 5 = 15
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then the 50% time should used for each batch rather that
the total time. Any time the product is covered or
protected from airborne deposition should also be taken
into consideration.
Using these variables as indicated in Equation 4, the
number of microorganisms deposited during a
manufacturing operation can be calculated as shown in the
following example of high airborne contamination:
Example: Containers are filled within a unidirectional
flow workstation. Several settle plates are exposed for
four hours in the area adjacent to the open containers.
The average microbial count from the 14 cm diameter
Petri dishes (154 cm2 area) was found to be 1.
The deposition rate (no./(cm2.hr)) of the microorganisms
can be calculated from the settle plate data i.e.
Deposition rate (no./(cm2.hr)) = average count on settle
plate ÷ [area of Petri dish (cm2) × time plate exposed (hr)] 
= 1 ÷ [154 × 4] = 0.0016
The container has an inner neck area of 2 cm2 and is open
to contamination during filling for an average of 10
minutes. The number of microbes that would contaminate
the product by depositing through the neck area is then
calculated from Equation 4, although the units used are
hours instead of seconds i.e.
No of airborne microbes deposited into product in a
given time = deposition rate (no./(cm2.hr)) × exposed
product surface area (cm2) × time of product exposure(hr)
= 0.0016× 2× [10 ÷ 60] = 5.4 × 10–4
It is a reasonable assumption that microbe-carrying
particles will be deposited randomly throughout
production11 and therefore 5.4 containers in 10,000 will
be contaminated.
Clearly, a contamination rate of about 1 in 2000 is
unacceptable and must be improved. If the time the
product is exposed, its surface area, or the airborne
microbial concentration is reduced, then the
contamination rate can be reduced; this can be calculated.
If, for example, the filling time is reduced to 6 seconds,
the airborne contamination of containers will be reduced
100 times to 5.4 containers in a million.
Reduction of the risk of microbial airborne deposition
The previous section demonstrates that the risk of airborne
contamination is dependent on the microbial deposition
rate, the exposure time, and the deposition area, and can
be readily calculated. It may be possible, especially at the
design stage, to reduce the exposure time and deposition
area by redesigning the process. However, the possibility
of reducing microbial deposition onto the product requires
the assistance of risk assessment.
Pharmaceutical products open to microbial
contamination will be located in a EU Grade A
environment, as found within a separative air device such
as a unidirectional airflow workstation or cabinet, and this
will be located in a turbulently-ventilated EU Grade B or
C background cleanroom area. Airborne contamination
will then occur from two sources and routes. These are:
1. Air transferred from a Grade B or C cleanroom into
the separative air device. The amount of undesirable
transfer depends on the effectiveness of the separative
device in preventing the entry of airborne
contamination. 
2. Microorganisms dispersed from personnel into the air
within the critical area. The fundamental equations
predict that this depends on how much of their body is
within the critical area, the personnel’s microbial
dispersion rate, the effectiveness of their cleanroom
clothing in reducing dispersion, and the time
personnel is within the area.
A reduction in airborne contamination risk is best
achieved by separate consideration of these two sources.
Air transfer into the critical area. Ljungqvist and
Reinmuller12 have described a method that can be used to
determine the penetration of cleanroom air into an
enhanced air device. They suggest, firstly, that the airflow
round the area is investigated by smoke visualisation
techniques to gain an insight into any problems. The area
outside the enhanced air device is then seeded with a
known concentration of small airborne particles, and the
number of particles that penetrate into the critical area
during simulated production, is measured. The ratio of
particles found at the critical area to those seeded outside,
is then calculated and is used as an indication of risk. The
effectiveness of the enhanced air device in preventing
penetration of outside contamination can then be
investigated and its performance improved if required.
Reduction in airborne microbial contaminants
dispersed within the critical area: It is necessary to return
to the fundamental Equation 2 to determine the best risk
equation that can be used to assess risk. This is likely to be
similar to Equation 9.
Equation 9
Airborne risk = [amount of personnel’s body within area]
× [effectiveness of clothing] × [proportion of time
personnel are within critical zone during production]
The accuracy of the equation may be increased by
assigning weighting coefficients to balance the
contribution of risk, in the manner similar to that
undertaken for Equation 8.
The effectiveness of clothing is an important factor.
This can be ascertained by the use of a dispersal
chamber13, 14, but this apparatus is generally not available
outside the research laboratory. It may therefore be
necessary to assess clothing in terms of the following
descriptors: 
(a) how well the clothing envelopes the body; 
(b) the effectiveness of the clothing fabric in filtering the
body’s emissions [use of the pore diameter of
interstices of the fabric, and the particle penetration
through the fabric 13, 14 ]; and 
(c) the prevention of body debris being pumped out from
insufficiently sealed openings at the neck, face, cuffs
and ankles.
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A risk assessment should then be carried out by a method
similar to that described in Section 3 and steps taken,
where possible, to reduce the degree of risk by:
(1) reducing the amount of a persons body within the
critical area; 
(2) improving the effectiveness of cleanroom clothing
and; 
(3) reducing the time within the critical area.
The effectiveness of the reduction of risk by use of one or
both of these methods described above can be determined
by settle plate sampling.
Discussion
The use of risk management systems is well establish in
the electrical and mechanical industries, but seldom used
in managing microbial risk in aseptic pharmaceutical
manufacturing. Various risk management methods are
available but the HACCP system, being devised for the
food industry, is probably the best system to use with
microbial contamination in pharmaceutical cleanrooms.
A major component of risk management is risk
assessment, where the degree of risk for each hazard is
assessed. Described within this paper are risk assessment
systems based on fundamental models of microbial
contamination that allow the most effective risk
assessment methods to be utilised and support the
established FMECA method of assessing risk.
A method of risk assessment has been developed,
firstly, to provide an overall assessment of contamination
from all areas of the cleanroom. Secondly, a risk
assessment method has been developed that focuses on the
manufacturing process in the critical area and examines
separately the surface contact and airborne deposition
routes of contamination.
For surface contact contamination, using risk factors
that have either numerical values or descriptors of risk, a
risk rating can be calculated for each critical stage of a
manufacturing operation or a multiphase manufacturing
operation. By appropriate use of the values allocated to the
risk factors, the step, stage or phase of manufacture with
the highest risk can be identified and the risks addressed
accordingly. 
For airborne contamination, the fundamental equation
used to calculate airborne contamination is well
established and hence the associated contamination rate in
the critical area can be readily calculated. Reductions in
product exposure time and deposition area can, if
necessary, be effected to reduce the microbial risk and
overall contamination rate. However, a further risk
assessment method will be required to assess and reduce
the risk from airborne contamination.
Manufacturing stages, or steps, with the highest risk
ratings can, if deemed unacceptable, be modified or
amended to reduce the microbial risk. At some stage,
however, the question of what is an acceptable level of
risk will be encountered. This may arise because further
reductions in the risk rating are not possible, or significant
capital expenditure and investment in new items of
equipment is required. At this stage, agreement between
manufacturing, engineering and quality assurance
personnel, utilising the risk data and other relevant
supporting information (e.g. ongoing environmental
microbiological results, sterility test results, and product
simulation test data) will be required, as well as
consideration of the potential microbial risk to the patient.
Utilisation of a risk management system will assist in this
task.
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